$CIIX WallStreet Research™ Issues Updated Corporate Profile on ChineseInvestors.com

NEW YORK, September 5, 2017

WallStreet Research™ (WSR), a top-ranked independent research firm with a history spanning over three decades, today announced that the firm has updated Corporate Profile coverage on ChineseInvestors.com Inc. (OTCQB: CIIX).  WallStreet Research™ is ranked Number One on the Google, Yahoo, and Bing search engines in both small and microcap research with a global following.  An updated analyst Corporate Profile Report, together with additional information about WallStreet Research™, is available at the http://www.WallStreetResearch.org website. The WSR Corporate Profile highlights the Company’s recent accomplishments and growth plans for 2017 and beyond.

Founded in 1999, ChineseInvestors.com, Inc. (“CIIX” or “the Company”) headquartered in San Gabriel, California, with offices in New York and Shanghai China, is a premier financial information website for Chinese speaking investors. http://www.Chinesefn.com, provides web-based, timely market information about United States publicly traded stocks and foreign currencies with free quotes, charts, market news, and links to investment research. The Company recently announced it is planning to launch the first Chinese Daily Video News Broadcast from the NYSE floor covering cryptocurrencies and Bitcoin currency.  CEO, Mr. Warren Wang, an expert in the cryptocurrency market, will be able to add his commentary to the daily broadcasts on the Company’s website at http://www.ChineseFN.com .   The Company earlier announced it is launching cryptocurrency education and trading subscription services on its ChineseFN.com website platform to subscribers.

The Company currently tracks United States stock market quotes and provides access to sample investment portfolios for educational purposes, as well as real-time trading demonstrations. Through its relationship with Phoenix Television, the Company produces and broadcasts a weekly television show covering the financial markets entitled “Wall Street Weekly.” In addition, CIIX offers a wide range of investor relations services to publicly-traded companies in the United States and China. CIIX went public in 2011 and has profited from earning and holding shares in publically traded companies through its consulting and advisory services over the past few years.

In recognition of the unprecedented opportunities in the non-industrial hemp industry, CIIX has expanded its business to capitalize on the growing demand for non-industrial hemp based products including healing oils, food products, and other health and beauty products.  CIIX has opened its retail store “Chinese Wellness Center” in the predominantly Chinese community of San Gabriel, California.  In addition, CIIX announced its release of its first CBD oil product line, “OptHemp™”, a premium, private label oil, made from full-spectrum, Colorado grown, GMO-Free, non-industrial hemp, manufactured using a CO2 Extraction process. As part of its expansion, the Company also has established a wholly owned foreign enterprise, “XiBiDi Biotechnology Co. Ltd,” also known as CBD Biotechnology Co. Ltd., which operates its site ChineseCBDoil.com. In May 2017, CBD Biotechnology appointed Summer (XiangYang) Yun as CEO.  Yun’s initial focus will be the launch o “CBD Magic Hemp Series” cosmetics line, which is expected to launch this quarter with 3-5 CBD-based core skin care products.  Yun is a marketing and branding executive with over 25 years of experience. CBD Biotechnology Co., Ltd. plans to use multiple sales channels to implement its sales plan.

The Company filed its most recent 10K report for the year ended May 31, 2017, and reported total revenues of $1.67 million, up from $.95 million in the previous year, a growth rate of 76%.  The growth in revenues consisted of strong revenue growth from subscription sales and from increased investor relations and consulting activities.  The operating loss was $4.9 million vs. $2.9 million, and EPS was ($.86) vs. ($.26) from the prior fiscal year.  The Company had incurred additional costs related to its growth strategy of adding several new lines of business including the ChineseHempOil.com activities, CBD Biotechnology, and others.

The Company in its 10K filing announced it has authorized up to 10 million shares in Series D Convertible Preferred Stock to accredited investors at $1 per share, each share converting into two shares of common, with a 6% annual dividend for two years.  It has thus far completed approximately $2 million of the offering.

Mr. Alan Stone, Managing Director of WallStreet Research™ commented, “CIIX is gearing up for another year of strong growth with its new expanded business activities and improved financial position.”

About WallStreet Research™

WallStreet Research™ (“WSR”) is a prominent research boutique led by Mr. Alan Stone, Managing Director of Alan Stone & Company, LLC (ASC). The firm specializes in the microcap and small cap investment arena, looking for emerging growth companies with strong management, unique or proprietary technology, significant market potential, financial strength, and outstanding long-term earnings growth possibilities. The firm has offices in Los Angeles, CA, Palm Beach, FL, and New York City, NY, and is well known for discovering undervalued companies and bringing them to the attention of the investment community. ASC/WSR also arranges road shows for its publicly traded clients, before the investment community in New York City, California and Florida.

Information on WallStreet Research™ can be found at http://www.WallStreetResearch.org.

About ChineseInvestors.com, Inc. (CIIX)

ChineseInvestors.com, Inc., (CIIX), headquartered in Los Angeles, with offices in New York and Shanghai China, is a company that engages in providing a wide range of products, services, and information for the global Chinese population. Founded in 1999, CIIX endeavors to be an innovative company providing (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) support services to various partners; (c) consultative services to smaller private companies considering becoming a public company; (d) advertising and public relation related support services; and (e) other services they may identify having the potential to create value or partnership opportunity with their existing services.  http://www.Chinesefn.com.

The Company offers various products beyond its website information, the Company also offers a wide range of investor relations and is now beginning to change focus of solely being a premier Internet information provider by expanding into retail and online sales of CBD products via http://www.ChineseCBDoil.com and http://www.ChineseHempOil.com .

CIIX maintains its commitment to continue to grow its membership subscriptions and investor relations business thus adding to the potential for continued growth in the near future.

Information on CIIX can be found at http://www.ChineseInvestors.com.

Disclaimer

The information presented herein is not to be construed as an offer to sell, nor a solicitation of an offer to purchase, any securities. This corporate profile is not a research report, but a compilation of information available to the public, which has been furnished by the featured company or gathered from other sources, in each case without independent verification, and no representations are made as to the accuracy or validity thereof. The information may include certain forward-looking statements within the meaning of Section 21E of the Securities Exchange Commission Act of 1934, which may be affected by unforeseen circumstances or certain risks. Any investment in securities contains inherent risks and should only be done after consulting an investment professional. The featured company paid a fee of $3500 in cash to Alan Stone & Company LLC for preparation and distribution of this profile, including other potential fees associated with various consulting and investor relations’ services. For complete disclaimer information, readers are hereby referred to the Disclaimer Page at the http://www.WallStreetResearch.org website.

Contact / Source:

WallStreet Research™

Alan Stone, +1-310-444-3940
astone@alanstone.com

Barbara Blake, +1-415-419-4239
bjblake1229@att.net

http://www.WallStreetResearch.org
http://www.SouthFloridaInvestmentForum.com
http://www.SouthernCaliforniaInvestmentForum.com
http://www.SmallCapConference.org

ChineseInvestors.com Inc.
227 W. Valley Blvd. Suite 208 A
San Gabriel, CA 91776

Alan Klitenic, Investor Relations
+1(214)636-2548
Email: warrenwang@chinesefn.com
Headquarters: +1(888)789-1670

http://www.Chineseinvestors.com
http://www.Chinesefn.com
http://www.ChineseCBDoil.com
http://www.ChineseHempOil.com